Clinical Trials · NCT01722266
Liraglutide in the Treatment of Type 1 Diabetes Mellitus
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- University at Buffalo
- Enrollment
- 72
- Start date
- Nov 2012
- Locations
- 1 site, United States
- Primary endpoint
- Change in Mean Weekly Glucose Concentrations